Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioMarin Pharmaceutical Inc

+ Add to Watchlist

BMRN:US

128.7800 USD 13.2300 11.45%

As of 20:10:00 ET on 03/27/2015.

Snapshot for BioMarin Pharmaceutical Inc (BMRN)

Open: 125.0000 Day's Range: 123.0500 - 133.5400 Volume: 6,370,724
Previous Close: 115.5500 52wk Range: 55.0400 - 133.5400 1-Yr Rtn: +94.36%

Stock Chart for BMRN

No chart data available.
  • BMRN:US 128.7800
  • 1D
  • 1M
  • 1Y
115.5500
Interactive BMRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BMRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2074
Est. EPS (USD) (12/2015) -1.6740
Est. PEG Ratio -
Market Cap (M USD) 20,493.50
Shares Outstanding (M) 159.14
30 Day Average Volume 1,714,387
Price/Book (mrq) 12.5665
Price/Sale (ttm) 25.1243
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BMRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BMRN

BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.

Jean-Jacques BienaimeChief Executive OfficerDaniel K Spiegelman "Dan"Exec VP/CFO
Jeffrey R AjerExec VP/Chief Commercial OfcrHenry J FuchsExec VP/Chief Medical Officer
More Company Profile & Key Executives for BMRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil